Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: A three year study of radiographic progression, renal function, and arterial hypertension

Annals of the Rheumatic Diseases

Volumn 61, Issue 6, 2002, Pages 511-516

  Kvien, T K ^a   Zeidler, H K ^b   Hannonen, P ^c   Wollheim, F A ^d   Forre O ^e   Hafstrom I ^f   Kaltwasser, J P ^g   Leirisalo Repo, M ^h   Manger, B ⁱ   Laasonen, L ^j   Prestele, H ^k   Kurki, P ^l  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c Central Hospital of Middle Finland   (Finland)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF OSLO   (Norway)

^f KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^g GOETHE UNIVERSITY   (Germany)

^h HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁱ UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^j Surgical Hospital   (Finland)

^k NOVARTIS PHARMA AG   (Switzerland)

^l NATIONAL AGENCY FOR MEDICINES   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AUROTHIOMALATE; CREATININE; CYCLOSPORIN; CYCLOSPORIN A;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HYPERTENSION; KIDNEY DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIODIAGNOSIS; RHEUMATOID ARTHRITIS;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CREATININE; CYCLOSPORINE; DISABLED PERSONS; FEMALE; GOLD SODIUM THIOMALATE; HUMANS; HYPERTENSION; INJECTIONS; KIDNEY DISEASES; LONG-TERM CARE; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0036098031     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.61.6.511     Document Type: Article

References (45)

1. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis
2. Early rheumatoid arthritis - Onset, course, and outcome over 2 years
3. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease
4. New perspectives on controlling progression of severe rheumatoid arthritis - A summary of the potential role of cyclosporin
5. Rheumatoid arthritis: Treat now, not later!
6. Patients with rheumatoid arthritis benefit from early 2nd line therapy: 5 Year followup of a prospective double blind placebo controlled study
7. DC-ART: Preventing or significantly decreasing the rate of progression of structural joint damage
8. Does drug therapy slow radiographic deterioration in rheumatoid arthritis?
9. Progression in early erosive rheumatoid arthritis: 12 Month results from a randomized controlled trial comparing methotrexate and gold sodium thiomalate
10. DC-ART classification: Review of relevant clinical studies
11. Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: A 42-month prospective study
12. The role of current strategies in the future treatment of rheumatoid arthritis
13. Cyclosporine in rheumatoid arthritis: Documented efficacy and safety
14. Radiologic evidence of disease modification in rheumatoid arthritis patients treated with cyclosporine. Results of a 48-week multicenter study comparing low-dose cyclosporine with placebo
15. Cyclosporine in rheumatoid arthritis
16. Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A
17. Combination treatment of rheumatoid arthritis with cyclosporine and methotrexate
18. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis
19. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone
20. Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: Comparison of low-dose cyclosporin and parenteral gold
21. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
22. Standardized radiological evaluation of rheumatoid arthritis in therapeutic trials
23. The assessment of disability: From first to future principles
24. Prediction of creatinine clearance from serum creatinine
25. Development of radiographic damage during the first 5-6 yr of rheumatoid arthritis. A prospective follow-up study of a Swedish cohort
26. Smallest detectable difference in radiological progression
27. The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up
28. The links between joint damage and disability in rheumatoid arthritis
29. Scores for functional disability in patients with rheumatoid arthritis are correlated at higher levels with pain scores than with radiographic scores
30. Comparison of intramuscular gold and sulphasalazine in the treatment of early rheumatoid arthritis. A one year prospective study
31. Improved functional outcome in patients with early rheumatoid arthritis treated with intramuscular gold: Results of a five year prospective study
32. Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 Month data of a double-blind parallel study of 174 patients
33. Neoral - New cyclosporin for old?
34. The use of cyclosporin A in rheumatoid arthritis: Conclusions of an international review
35. Disease-modifying anti-rheumatic drugs. Cyclosporin
36. Renal toxicity of long-term cyclosporin
37. Morphological and functional renal effects of long-term low-dose cyclosporin A treatment in patients with rheumatoid arthritis
38. Longterm low dose cyclosporine in patients with rheumatoid arthritis: Renal function loss without structural nephropathy
39. Renal biopsy specimens from patients with rheumatoid arthritis and apparently normal renal function after therapy with cyclosporine
40. Renal biopsy findings and followup of renal function in rheumatoid arthritis patients treated with cyclosporin A. An update from the International Kidney Biopsy Registry
41. Renal biopsy findings in long-term cyclosporin treatment of psoriasis
42. The kidney in cyclosporin A-treated diabetic patients: A long-term clinicopathological study
43. Cyclosporin A therapy in rheumatoid arthritis: Only strict application of the guidelines for safe use can prevent irreversible renal function loss
44. The use of cyclosporin A microemulsion in rheumatoid arthritis: Conclusions of an international review
45. US consensus guidelines for the use of cyclosporin A in rheumatoid arthritis